Healthcare Realty Trust (NYSE:HR) Issues Quarterly Earnings Results, Misses Estimates By $0.46 EPS

Healthcare Realty Trust (NYSE:HR) issued its quarterly earnings data on Thursday. The real estate investment trust reported ($0.05) earnings per share for the quarter, missing the consensus estimate of $0.41 by ($0.46), FiscalAI reports. The business had revenue of $286.64 million for the quarter, compared to the consensus estimate of $275.27 million. Healthcare Realty Trust had a negative net margin of 3.96% and a negative return on equity of 1.00%. Healthcare Realty Trust’s revenue was down 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.41 EPS.

Healthcare Realty Trust Stock Up 1.8%

NYSE:HR traded up $0.32 during trading hours on Friday, hitting $18.45. 9,563,004 shares of the stock were exchanged, compared to its average volume of 5,628,419. The company’s 50 day moving average is $18.17 and its two-hundred day moving average is $18.81. The company has a market capitalization of $6.32 billion, a P/E ratio of -131.79 and a beta of 0.97. Healthcare Realty Trust has a twelve month low of $16.31 and a twelve month high of $22.04.

Healthcare Realty Trust Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 20th. Stockholders of record on Tuesday, November 10th will be given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date is Tuesday, November 10th. Healthcare Realty Trust’s dividend payout ratio is presently -369.23%.

Insider Activity

In other news, COO Robert Hull sold 21,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $19.11, for a total transaction of $401,310.00. Following the completion of the sale, the chief operating officer owned 276,338 shares in the company, valued at $5,280,819.18. The trade was a 7.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.56% of the company’s stock.

Wall Street Analyst Weigh In

HR has been the topic of several recent analyst reports. Royal Bank Of Canada lifted their price target on Healthcare Realty Trust from $21.00 to $22.00 and gave the stock a “sector perform” rating in a research report on Friday, August 7th. Wells Fargo & Company reduced their price objective on Healthcare Realty Trust from $20.00 to $18.00 and set an “equal weight” rating for the company in a research report on Monday, October 19th. Deutsche Bank Aktiengesellschaft upgraded shares of Healthcare Realty Trust from a “hold” rating to a “buy” rating and raised their price objective for the stock from $18.00 to $23.00 in a research note on Tuesday, October 20th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Healthcare Realty Trust in a research report on Wednesday. Finally, Jefferies Financial Group began coverage on shares of Healthcare Realty Trust in a research report on Tuesday, September 15th. They set a “hold” rating and a $20.00 target price on the stock. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $21.36.

Key Headlines Impacting Healthcare Realty Trust

Here are the key news stories impacting Healthcare Realty Trust this week:

• Positive Sentiment: Raised 2026 outlook: Healthcare Realty increased its normalized FFO guidance to $1.65–$1.67 per share, raising the midpoint by $0.02. Same-store cash NOI growth guidance was also lifted to 5.00%–5.25%, signaling improved expected property-level performance. Healthcare Realty Reports Third Quarter 2026 Results and Further Increases Full Year 2026 Guidance
• Positive Sentiment: FFO beat expectations: Third-quarter normalized funds from operations reached $0.42 per share, up from $0.41 a year earlier and above the $0.41 analyst consensus. FFO is a key valuation measure for REIT investors and helped offset concerns about the GAAP results. Healthcare Realty Trust Tops Q3 FFO and Revenue Estimates
• Positive Sentiment: Income return remains attractive: The company declared a quarterly dividend of $0.24 per share, or $0.96 annually, representing an indicated yield of approximately 5.3% based on the supplied trading data. Healthcare Realty Trust Dividend Information
• Neutral Sentiment: Share repurchase authorization: Reports referenced a $500 million equity buyback plan, which could support per-share value over time, although the plan dates back to 2025 and its current pace of execution was not specified. Healthcare Realty Trust Announces an Equity Buyback
• Negative Sentiment: GAAP results remained weak: HR reported a third-quarter loss of $0.05 per share versus $0.41 of earnings a year earlier, while revenue declined 3.4% year over year. The loss could limit enthusiasm if investors place greater weight on reported earnings than on adjusted FFO. Healthcare Realty Trust Third Quarter Earnings Results

Healthcare Realty Trust Company Profile

Healthcare Realty Trust Incorporated (NYSE: HR) is a real estate investment trust focused on owning, managing, acquiring and developing outpatient healthcare properties. Its portfolio primarily includes medical office buildings, ambulatory surgery centers, outpatient facilities and other properties used by healthcare providers.

The company leases space to health systems, physician groups and other healthcare organizations, with properties generally located on or near hospital campuses and in growing outpatient care settings.